NovelPoint Security and Verbatim Americas Settle Patent Dispute

Case Filed: Feb 01, 2013

Case Closed: May 24, 2013

Judge: Rodney Gilstrap

Court: Texas Eastern District Court

Case Summary:

The case filed by NovelPoint against Verbatim Americas has come to a conclusion as the parties have reached a settlement. 

NovelPoint filed a case against Verbatim for infringing their patent US5434562, which relates to computer security measures that prevent unauthorized reading/modifying computer data. The patent entitled ‘Method for limiting computer access to peripheral devices’ was issued on Jul 18, 1995 and expired[i] on Jul 18, 2012.

The patent is currently assigned[ii] to NovelPoint (source: MaxVal’s Assignment Database). The complaint stated that Verbatim Americas infringed the ‘562 patent by manufacturing devices such as Verbatim Encrypted USB Drives Store ‘n’ Go USB Drive – TAA Comp/FIPS Cert.

Later the parties agreed to settle the case and filed motion for dismissal. The Judge ordered dismissal of the case with prejudice, pursuant to settlement. The terms of agreement were not disclosed. 

See 2:13-cv-00094 for more details. To get alerts on cases filed/closed, subscribe to our Litigation Alerts.

Has this patent been litigated? Use our free tool or download our free Android/iOS app on Google Play/ App Store.

---

[i] Expected expiration date. Patent Term Estimator is a free web-based tool that automatically calculates patent terms and expiration dates for U.S. utility patents.

[ii] MaxVal offers Patent Assignment Alert service where subscribers receive email alerts when assignments relating to target applications, patents or entities of interest are recorded.

Galderma Settles Generic Epiduo Patent Suit with Par Pharmaceutical

Galderma Laboratories filed a lawsuit in the Northern District of Texas against Watson Pharmaceuticals.  Watson submitted an ANDA (abbreviated new drug application) no. 204067 seeking approval to engage in the commercial manufacture of generic Adapalene and Benzoyl Peroxide Gel, which according to Galderma infringes the claims of three of its patents. The patents involved in this suit were:

US8071644 - Combinations of adapalene and benzoyl peroxide for treating acne lesions and issued on Dec 06, 011.

US8080537 - Combinations of adapalene and benzoyl peroxide for treating acne lesions and issued on Dec 20, 2011

US8129362 - Combination/association of adapalene and benzoyl peroxide for treating acne lesions and issued on Mar 06, 2012

The patents expire[i] by Jul 13, 2026 and are currently assigned[ii] to Galderma (source: MaxVal’s Assignment Database). Galderma currently holds[iii] the NDA (new drug abbreviation) no. 022320 for Epiduo® gel to treat acne (source: MaxVal’s Patent Marker) approved by FDA in Dec, 2008. 

Par Pharmaceuticals substituted Watson during the prosecution. The case is now closed as the parties have filed for stipulated dismissal and the Court ordered dismissal upon the request. However, no further information is available on the terms of settlement.

Case Filed: Jul 27, 2012

Case Closed: May 21, 2013

Judge: Ed Kinkeade

Court: Texas Northern District Court

See 3:12-cv-02563 for more details. To get alerts on cases filed/closed, subscribe to our Litigation Alerts.

Has this patent been litigated? Use our free tool or download our free Android/iOS app on Google Play/ App Store.

---

[i] Expected expiration date. Patent Term Estimator is a free web-based tool that automatically calculates patent terms and expiration dates for U.S. utility patents.

[ii] MaxVal offers Patent Assignment Alert service where subscribers receive email alerts when assignments relating to target applications, patents or entities of interest are recorded.

[iii] Patent Marker provides an online environment where patentees can virtually mark products and search products for patent-related information.

Lawsuit Summary - SmartPhone vs. Apple and AT&T

Plaintiff: SmartPhone Technologies LLC

Defendant: Apple Inc., AT&T Inc. and AT&T Mobility LLC

A case (6:13-cv-00196) was filed in the Eastern District of Texas on Feb 25^th for patent infringement. The patents involved in this suit are US7076275 (Method and system for single-step enablement of telephony functionality for a portable computer system), US7506064 (Handheld computer system that attempts to establish an alternative network link upon failing to establish a requested network link), RE40459 (Method and apparatus for communicating information over low bandwidth communications networks) and US7533342 (System and method of a personal computer device providing telephone capability). All these patents are currently assigned[*] to Access Co. Ltd. (source: MaxVal’s Assignment Database). SmartPhone is the exclusive licensee of the 4 patents as per the complaint. 

The ‘275, ‘064 and ‘342 patents relate to the field of portable electronic devices such as personal digital assistants or palmtop computer systems. They allow a background task to run on a portable electronic device facilitating telephony functionality. The ‘459 patent relates to the field of information communications and to low bandwidth network access to internet based information.

Complaint alleges that Apple is manufacturing and marketing computerized communication devices including iPhone4S, iPad2, iPad3, iPad4 and iPad mini, which infringe the methods claimed in the patents-in-suit. 

Another case (6:13-cv-00197) was filed on the same day against LG Electronics asserting the patent US7076275. If you are interested in knowing more about the cases filed, please contact us. To get alerts on cases filed, subscribe to our Litigation Alerts. 

Has this patent been litigated? Use our free tool or download our free Android app on Google Play.

---

[*] MaxVal offers Patent Assignment Alert service where subscribers receive email alerts when assignments relating to target applications, patents or entities of interest are recorded.

Delhaize America Hit with Patent Suit over Automated Refill System

Plaintiff: CompuFill

Defendant: Delhaize America

Delhaize America is being hit by CompuFill with patent infringement case (1:13-cv-00041) on Feb 14^th in North Carolina District Court. Delhaize America through its subsidiaries operates retail food supermarkets in the eastern United States. The company’s supermarkets sell various grocery, produce, meat, dairy, seafood, frozen food, and deli-bakery products, as well as non-food items, such as health and beauty care products, prescription medicines, and other household and personal products. 

Patent-in-suit includes US6728684 (On-Line Pharmacy Automated Refill System) and it is currently assigned[i] to CompuFill (Source: Maxval’s Assignment Database). The patent relates to the field of refilling patient prescriptions using telephone and computer equipment even if patient databank computer interactive communications are unavailable.

The complaint says that defendant infringes the above patent through the automated system for requesting prescription refills. It also says that the methods for processing requests for prescription refills is covered by the claims of the ‘684 patent. 

The plaintiff has filed other infringement suits (1:13-cv-00041, 3:13-cv-00096) on the same day asserting the same patent on substantially the same product. If you are interested in knowing more about the cases, please contact us. To get alerts on cases filed, subscribe to our Litigation Alerts. 

Has this patent been litigated? Use our free tool or download our free Android app on Google Play.

---

[i] MaxVal offers Patent Assignment Alert service where subscribers receive email alerts when assignments relating to target applications, patents or entities of interest are recorded.